Blair William & Co. IL Acquires 14,967 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• Blair William & Co. IL increased its stake in Prestige Consumer Healthcare by 16.4% during the first quarter, acquiring an additional 14,967 shares to own 106,114 shares total, valued at approximately $9.12 million.
• Prestige Consumer Healthcare reported an EPS of $1.32 for the last quarter, surpassing market expectations, with revenues totaling $296.52 million, reflecting a 7.0% increase year-over-year.
• Analyst ratings for Prestige Consumer Healthcare have been generally positive, with a consensus rating of "Moderate Buy" and an average target price of $93.33.

Blair William & Co. IL increased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 16.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 106,114 shares of the company's stock after purchasing an additional 14,967 shares during the period. Blair William & Co. IL owned approximately 0.21% of Prestige Consumer Healthcare worth $9,123,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Jefferies Financial Group Inc. bought a new stake in Prestige Consumer Healthcare during the 1st quarter worth $203,000. Pacific Capital Partners Ltd bought a new stake in Prestige Consumer Healthcare during the 1st quarter worth $1,075,000. XTX Topco Ltd grew its position in Prestige Consumer Healthcare by 354.0% during the 1st quarter. XTX Topco Ltd now owns 22,778 shares of the company's stock worth $1,958,000 after acquiring an additional 17,761 shares during the last quarter. Texas Yale Capital Corp. grew its position in Prestige Consumer Healthcare by 22.7% during the 1st quarter. Texas Yale Capital Corp. now owns 7,239 shares of the company's stock worth $622,000 after acquiring an additional 1,339 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in Prestige Consumer Healthcare by 11.3% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,304 shares of the company's stock worth $1,058,000 after acquiring an additional 1,251 shares during the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Trading Down 3.0%

Shares of NYSE PBH traded down $2.00 during trading on Friday, reaching $65.61. The company had a trading volume of 785,601 shares, compared to its average volume of 440,546. The company's fifty day moving average price is $79.26 and its 200-day moving average price is $82.02. Prestige Consumer Healthcare Inc. has a 12 month low of $63.78 and a 12 month high of $90.04. The stock has a market cap of $3.24 billion, a P/E ratio of 15.40, a PEG ratio of 2.03 and a beta of 0.43. The company has a quick ratio of 2.82, a current ratio of 4.38 and a debt-to-equity ratio of 0.55.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The company had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. During the same quarter last year, the firm posted $0.90 EPS. The company's quarterly revenue was down 6.6% on a year-over-year basis. As a group, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on PBH. Wall Street Zen lowered Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday. Canaccord Genuity Group reduced their price objective on Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research report on Friday. Finally, Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.